161 related articles for article (PubMed ID: 25628047)
21. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
[TBL] [Abstract][Full Text] [Related]
22. S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer.
Malmström P; Bendahl PO; Boiesen P; Brünner N; Idvall I; Fernö M;
J Clin Oncol; 2001 Apr; 19(7):2010-9. PubMed ID: 11283134
[TBL] [Abstract][Full Text] [Related]
23. Prognostic influence of BCL2 expression in breast cancer.
Hwang KT; Woo JW; Shin HC; Kim HS; Ahn SK; Moon HG; Han W; Park IA; Noh DY
Int J Cancer; 2012 Oct; 131(7):E1109-19. PubMed ID: 22418857
[TBL] [Abstract][Full Text] [Related]
24. Impact of immediate breast reconstruction on breast cancer recurrence and survival.
Nedumpara T; Jonker L; Williams MR
Breast; 2011 Oct; 20(5):437-43. PubMed ID: 21601458
[TBL] [Abstract][Full Text] [Related]
25. A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models.
Nematolahi S; Ayatollahi SMT
Epidemiol Health; 2017; 39():e2017043. PubMed ID: 29056033
[TBL] [Abstract][Full Text] [Related]
26. Validity of the online PREDICT tool in older patients with breast cancer: a population-based study.
de Glas NA; Bastiaannet E; Engels CC; de Craen AJ; Putter H; van de Velde CJ; Hurria A; Liefers GJ; Portielje JE
Br J Cancer; 2016 Feb; 114(4):395-400. PubMed ID: 26783995
[TBL] [Abstract][Full Text] [Related]
27. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
Masarwah A; Auvinen P; Sudah M; Dabravolskaite V; Arponen O; Sutela A; Oikari S; Kosma VM; Vanninen R
BMC Cancer; 2016 Nov; 16(1):833. PubMed ID: 27806715
[TBL] [Abstract][Full Text] [Related]
28. The Nottingham Prognostic Index in primary breast cancer.
Galea MH; Blamey RW; Elston CE; Ellis IO
Breast Cancer Res Treat; 1992; 22(3):207-19. PubMed ID: 1391987
[TBL] [Abstract][Full Text] [Related]
29. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
Campbell HE; Gray AM; Harris AL; Briggs AH; Taylor MA
Br J Cancer; 2010 Sep; 103(6):776-86. PubMed ID: 20823886
[TBL] [Abstract][Full Text] [Related]
30. Prognosis of synchronous bilateral breast cancer.
Irvine T; Allen DS; Gillett C; Hamed H; Fentiman IS
Br J Surg; 2009 Apr; 96(4):376-80. PubMed ID: 19283743
[TBL] [Abstract][Full Text] [Related]
31. Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer.
Suen D; Chow LW
Biomed Pharmacother; 2006 Jul; 60(6):293-7. PubMed ID: 16828252
[TBL] [Abstract][Full Text] [Related]
32. Failure event types and prognostic factors after node-positive breast cancer in patients treated by adjuvant chemotherapy: impact on follow-up.
Filleron T; Kramar A; Dalenc F; Spielmann M; Fumoleau P; Kerbrat P; Martin AL; Roché H
Bull Cancer; 2012 Jun; 99(6):E64-74. PubMed ID: 22641367
[TBL] [Abstract][Full Text] [Related]
33. Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes.
Sidoni A; Bellezza G; Cavaliere A; Del Sordo R; Scheibel M; Bucciarelli E
Breast; 2004 Feb; 13(1):23-7. PubMed ID: 14759712
[TBL] [Abstract][Full Text] [Related]
34. The Nottingham prognostic index for invasive carcinoma of the breast.
Lee AH; Ellis IO
Pathol Oncol Res; 2008 Jun; 14(2):113-5. PubMed ID: 18543079
[TBL] [Abstract][Full Text] [Related]
35. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.
Chang JM; McCullough AE; Dueck AC; Kosiorek HE; Ocal IT; Lidner TK; Gray RJ; Wasif N; Northfelt DW; Anderson KS; Pockaj BA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S509-15. PubMed ID: 26001860
[TBL] [Abstract][Full Text] [Related]
36. Nottingham Clinico-Pathological Response Index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer.
Abdel-Fatah TM; Ball G; Lee AH; Pinder S; MacMilan RD; Cornford E; Moseley PM; Silverman R; Price J; Latham B; Palmer D; Chan A; Ellis IO; Chan SY
Clin Cancer Res; 2015 Mar; 21(5):1052-62. PubMed ID: 25520390
[TBL] [Abstract][Full Text] [Related]
37. [Breast cancer in young women in the south of Tunisia].
Khanfir A; Frikha M; Kallel F; Meziou M; Trabelsi K; Boudawara T; Mnif J; Daoud J
Cancer Radiother; 2006 Dec; 10(8):565-71. PubMed ID: 17140835
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
Jiang WG; Douglas-Jones AG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
[TBL] [Abstract][Full Text] [Related]
39. [Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?].
Kroman NT; Jensen MB; Wohlfahrt J; Mouridsen H; Andersen PK; Melbye M
Ugeskr Laeger; 2000 May; 162(22):3184-8. PubMed ID: 10850209
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
